Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients

被引:8
|
作者
Kim, Ji Eun [1 ]
Yu, Mi-Yeon [2 ]
Kim, Yong Chul [1 ]
Min, Sang-il [3 ]
Ha, Jongwon [3 ]
Lee, Jung Pyo [4 ]
Kim, Dong Ki [1 ,5 ]
Oh, Kook-Hwan [1 ]
Joo, Kwon-Wook [1 ,5 ]
Ahn, Curie [1 ,5 ]
Kim, Yon Su [1 ,5 ]
Lee, Hajeong [1 ,5 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehakro, Seoul 03080, South Korea
[2] Hanyang Univ, Guri Hosp, Dept Internal Med, Guri, South Korea
[3] Seoul Natl Univ, Transplantat Res Lab, Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea
[4] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea
关键词
Cholesterol; Cardiovascular; TG; HDL-C; Statins; Kidney transplantation; CORONARY-HEART-DISEASE; CARDIAC OUTCOMES; DYSLIPIDEMIA; INDIVIDUALS; FLUVASTATIN; PREVALENCE; PREVENTION; FAILURE; LIPIDS; DEATH;
D O I
10.1007/s10157-019-01776-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Dyslipidemia is common in kidney transplant (KT) recipients. We analyzed the ratio of triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) in KT recipients to identify risk factors for major cardiovascular events (MACE). Methods We retrospectively included KT recipients with a lipid profile performed 1 year after transplantation. We classified patients according to the TG/HDL-C divided into quintiles. Subsequently, we analyzed the association between TG/HDL-C and MACE, defined as heart failure, coronary artery disease, and cerebrovascular disease confirmed by imaging studies. Results A total of 1301 KT recipients were enrolled. The median follow-up duration was 7.4 years (interquartile range 4.4-11.1 years). During the follow-up period, 80 (6.2%) patients developed MACE, which included 38 of unstable anginas, 9 of MIs, 19 of heart failures, 18 of cerebral infarcts, and 4 of cerebral hemorrhages. The fourth and fifth quintiles of TG/HDL-C showed a significantly increased risk of MACE [fourth quintile: adjusted hazard ratio (aHR), 3.38; 95% confidence interval (CI) 1.44-7.95; p = 0.005, fifth quintile: aHR, 2.67; 95% CI 1.13-6.30; p = 0.02]) compared to the second quintile of TG/HDL-C. This association is particularly evident in subgroups of non-DM, HTN, no history of CVD, and statin users. Conclusions Higher TG/HDL-C levels may be associated with MACE risk in KT recipients.
引用
收藏
页码:1407 / 1417
页数:11
相关论文
共 50 条
  • [31] Proatherogenic changes in lipoprotein particles associated with a high triglyceride to high-density lipoprotein cholesterol ratio in youths
    Chiriaco, Martina
    Nesti, Lorenzo
    Natali, Andrea
    Santoro, Nicola
    Caprio, Sonia
    Trico, Domenico
    OBESITY, 2023, 31 (07) : 1894 - 1902
  • [32] Association between triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes risk in Japanese
    Wang, Huijuan
    Wang, Changming
    Xuan, Xiuping
    Xie, Zhouni
    Qiu, Yuanyuan
    Qin, Huiping
    Xiaoning, Zhong
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [33] Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data
    Bizhong Che
    Chongke Zhong
    Ruijie Zhang
    Liyuan Pu
    Tian Zhao
    Yonghong Zhang
    Liyuan Han
    Cardiovascular Diabetology, 22
  • [34] Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data
    Che, Bizhong
    Zhong, Chongke
    Zhang, Ruijie
    Pu, Liyuan
    Zhao, Tian
    Zhang, Yonghong
    Han, Liyuan
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [35] Association between triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes risk in Japanese
    Huijuan Wang
    Changming Wang
    Xiuping Xuan
    Zhouni Xie
    Yuanyuan Qiu
    Huiping Qin
    Zhong Xiaoning
    Scientific Reports, 13
  • [36] Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol
    Toth P.P.
    Current Atherosclerosis Reports, 2007, 9 (1) : 81 - 88
  • [37] The importance of high-density lipoprotein cholesterol in the management of cardiovascular risk
    Maritz, FJ
    SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (03): : 232 - 233
  • [38] Modification of high-density lipoprotein cholesterol in the management of cardiovascular risk
    Koeller, J
    Talbert, RL
    PHARMACOTHERAPY, 2002, 22 (10): : 1266 - 1277
  • [39] High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events
    Fonarow, GC
    Watson, KE
    AMERICAN HEART JOURNAL, 2004, 147 (06) : 939 - 941
  • [40] Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B
    Hanak, V
    Munoz, J
    Teague, J
    Stanley, A
    Bittner, V
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (02): : 219 - 222